Current Diagnosis and Management of Small-Cell Lung Cancer

Mayo Clinic Proceedings
Shuhang WangAlex A Adjei

Abstract

Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics from non-small-cell lung cancer. SCLC has high metastatic potential, resulting in a clinically poor prognosis. Early concurrent chemo-radiation is the standard of care for limited-stage SCLC (LS-SCLC). Prophylactic cranial irradiation (PCI) is recommended for patients with LS-SCLC without progression of disease after initial therapy. A combination of etoposide and cisplatin or carboplatin remains the mainstay of first-line treatment for ES-SCLC, with the addition of atezolizumab, now becoming standard. Most SCLCs initially respond to therapy but almost invariably recur. Topotecan and amrubicin (in Japan) remain the primary chemotherapy options for relapsed SCLC. Immunotherapy, including nivolumab with or without ipilimumab, is now available for refractory disease. In general, the poor prognosis of SCLC has not improved significantly for more than 3 decades. Recently, next-generation molecular profiling studies have identified new therapeutic targets for SCLC. A variety of proapoptotic agents, compounds capitalizing on DNA-repair defects, immunotherapy agents, and antibody-drug conjugates are being evaluated...Continue Reading

Citations

Sep 30, 2020·Drugs·James E Frampton
Apr 14, 2020·Cell Biology International·Yuwen WangShi Xu
Jan 29, 2021·Journal of Medicinal Chemistry·Stephen D RichbartPiyali Dasgupta
Jan 21, 2021·International Journal of Environmental Research and Public Health·Claudia MusialMagdalena Gorska-Ponikowska
Oct 23, 2020·International Journal of Molecular Sciences·Kentaro FujiwaraTakao Hamakubo
Feb 3, 2020·Cancer Treatment and Research Communications·Hussein A Assi, Sukhmani K Padda
Feb 20, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Win Sen HengFrank A E Kruyt
Oct 28, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Maurice PérolSolange Peters
Oct 15, 2020·Expert Opinion on Drug Delivery·Nathalie WauthozKarim Amighi
May 9, 2021·BMJ Case Reports·Udara Dilrukshi SenarathneBandu Gunasena
May 20, 2021·Analytical Cellular Pathology (Amsterdam)·Fan ZhangWen Meng
Jun 11, 2021·Current Treatment Options in Oncology·Kazhan MollazadeganJoakim Crona
Mar 17, 2021·Cold Spring Harbor Molecular Case Studies·Noah E BerlowCharles Keller
May 6, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersPeter M Ellis
Jun 11, 2021·International Journal of Cancer. Journal International Du Cancer·Manuel Dómine GómezJanakiraman Subramanian
Aug 3, 2021·Thoracic Cancer·Fan-Jie MengGuang-Shun Wang
Jun 30, 2021·Journal of the Chinese Medical Association : JCMA·Chi-Lu ChiangYuh-Min Chen
Nov 4, 2021·Targeted Oncology·Zaina T Al-Salama
Nov 11, 2021·Lung·Sara TariqHaiying Cheng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.